Patent details
EP3516060
Title:
ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE
Basic Information
- Publication number:
- EP3516060
- PCT Application Number:
- EP2017074133
- Type:
- European Patent Granted for LU
- Legal Status:
- In force
- Application number:
- EP177810306
- PCT Publication Number:
- WO2018055134
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- ANTISENSE OLIGONUCLEOTIDES FOR THE TREATMENT OF EYE DISEASE
- French Title of Invention:
- OLIGONUCLÉOTIDES ANTISENS POUR LE TRAITEMENT DE MALADIES OCULAIRES
- German Title of Invention:
- ANTISENSE-OLIGONUKLEOTIDE ZUR BEHANDLUNG VON AUGENERKRANKUNGEN
- SPC Number:
-
Dates
- Filing date:
- 22/09/2017
- Grant date:
- 21/07/2021
- EP Publication Date:
- 31/07/2019
- PCT Publication Date:
- 29/03/2018
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 21/07/2021
- EP B1 Publication Date:
- 21/07/2021
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- Expiration date:
- 22/09/2037
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 14/07/2021
-
-
- Name:
- ProQR Therapeutics II B.V.
- Address:
- Zernikedreef 9, 2333 CK Leiden, Netherlands (NL)
Agent
- Name:
- OFFICE FREYLINGER S.A.
- From:
- 26/07/2021
- Address:
- Boîte Postale 48, L-8001, STRASSEN, Luxembourg (LU)
- To:
Inventor
1
- Name:
- CHAN, Hee Lam
- Address:
- Netherlands (NL)
2
- Name:
- TURUNEN, Janne Juha
- Address:
- Netherlands (NL)
3
- Name:
- VAN DIEPEN, Hester Catharina
- Address:
- Netherlands (NL)
Priority
- Priority Number:
- 201616202
- Priority Date:
- 23/09/2016
- Priority Country:
- United Kingdom (GB)
Classification
- IPC classification:
-
C12N 15/113;
A61K 31/7088;
A61K 31/712;
A61P 27/02;
Publication
European Patent Bulletin
1
- Issue number:
- 202129
- Publication date:
- 21/07/2021
- Description:
- Grant (B1)
2
- Issue number:
- 202133
- Publication date:
- 18/08/2021
- Description:
- Application number/publication number of the divisional application (Art. 76) changed
Annual Fees
- Annual Fee Due Date:
- 30/09/2026
- Annual Fee Number:
- 10
- Annual Fee Amount:
- 131 Euro
- Expected Payer:
-
- Last Annual Fee Payment Date:
- 28/08/2025
- Last Annual Fee Paid Number:
- 9
- Last Annual Fee Paid Amount:
- 115 Euro
- Payer:
- ACUMASS SARL